NunaBio Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$8.73M
- Investors
-
14
NunaBio General Information
Description
Manufacturer of synthetic genetic material designed for the rapid production of high-complexity DNA constructs. The company's technology utilizes cell-free enzymatic manufacturing and modular micro-foundries to produce synthetic DNA constructs, long deoxyribonucleic acid products, short deoxyribonucleic acid products, DNA biosensors, consumables, and oligonucleotides, enabling biotechnology organizations to access scalable genetic material for the development of vaccines and gene therapies.
Contact Information
Website
www.nunabio.comCorporate Office
- The Biosphere Draymans Way
- Newcastle Helix
- Newcastle Upon Tyne NE4 5BX
- England, United Kingdom
Corporate Office
- The Biosphere Draymans Way
- Newcastle Helix
- Newcastle Upon Tyne NE4 5BX
- England, United Kingdom
NunaBio Timeline
NunaBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 30-Apr-2026 | $8.73M | Completed | Generating Revenue | ||
| 6. Later Stage VC | 16-Sep-2024 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 13-Dec-2023 | Completed | Generating Revenue | |||
| 4. Seed Round | 02-May-2023 | Completed | Generating Revenue | |||
| 3. Seed Round | 04-Apr-2021 | Completed | Generating Revenue | |||
| 2. Grant | 01-Apr-2021 | $415K | Completed | Generating Revenue | ||
| 1. University Spin-Out | 01-Jun-2012 | Completed | Generating Revenue |
NunaBio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | ||||||||
| Ordinary | ||||||||
| A Ordinary | ||||||||
| Ordinary | 111,674 | $0.013431 | $7.21 | $7.21 | 1x | $7.21 | 8.88% | |
| Ordinary | 59,600 | $0.013431 | $4.51 | $4.51 | 1x | $4.51 | 4.74% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NunaBio Comparisons
Industry
Financing
Details
NunaBio Competitors (88)
One of NunaBio’s 88 competitors is ProSci (Biotechnology), a Private Equity-Backed company based in Poway, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ProSci (Biotechnology) | Private Equity-Backed | Poway, CA | ||||
| Basecamp Research | Venture Capital-Backed | London, United Kingdom | ||||
| Integrated DNA Technologies | Formerly PE-Backed | Coralville, IA | ||||
| Twist Bioscience | Formerly VC-backed | South San Francisco, CA | ||||
| Adaptyv | Venture Capital-Backed | Lausanne, Switzerland |
NunaBio Patents
NunaBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202412718-D0 | Junction regions, templates and method for nucleic acid synthesis | Pending | 30-Aug-2024 | ||
| GB-2644434-A | Junction regions, templates and methods for nucleic acid synthesis | Pending | 30-Aug-2024 | ||
| WO-2026047131-A1 | Templates and methods for nucleic acid synthesis | Pending | 30-Aug-2024 | ||
| GB-2638211-A | A nucleic acid assembly method using type iib enzymes | Pending | 15-Feb-2024 | ||
| WO-2025172578-A1 | A nucleic acid assembly method using type iib enzymes | Pending | 15-Feb-2024 | C12N15/10 |
NunaBio Signals
NunaBio Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ascension Ventures | Corporate Venture Capital | Minority | ||
| HIT Investments | Asset Manager | Minority | ||
| Mason Capital | Corporation | Minority | ||
| EMV Capital | Venture Capital | Minority | ||
| North East Fund | Venture Capital | Minority |
NunaBio FAQs
-
When was NunaBio founded?
NunaBio was founded in 2012.
-
Where is NunaBio headquartered?
NunaBio is headquartered in Newcastle Upon Tyne, United Kingdom.
-
What is the size of NunaBio?
NunaBio has 21 total employees.
-
What industry is NunaBio in?
NunaBio’s primary industry is Discovery Tools (Healthcare).
-
Is NunaBio a private or public company?
NunaBio is a Private company.
-
What is the current valuation of NunaBio?
The current valuation of NunaBio is .
-
What is NunaBio’s current revenue?
The current revenue for NunaBio is .
-
How much funding has NunaBio raised over time?
NunaBio has raised $12.4M.
-
Who are NunaBio’s investors?
Ascension Ventures, HIT Investments, Mason Capital, EMV Capital, and North East Fund are 5 of 14 investors who have invested in NunaBio.
-
Who are NunaBio’s competitors?
ProSci (Biotechnology), Basecamp Research, Integrated DNA Technologies, Twist Bioscience, and Adaptyv are some of the 88 competitors of NunaBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process